PLURISTEM THERAPEUTICSCS INC
PLURISTEM THERAPEUTICSCS INC
Acción · US72940R3003 · PSTI · A2PPB4 (XNMS)
Resumen Indicadores financieros
Sin cotización
n/a

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
- - - - 0,00 % 0,00 % -87,05 %

Perfil de la empresa para PLURISTEM THERAPEUTICSCS INC Acción

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.

Datos de la empresa

Nombre PLURISTEM THERAPEUTICSCS INC
Empresa Pluristem Therapeutics Inc.
Símbolo PSTI
Sitio web https://www.pluristem.com
Mercado principal XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2PPB4
ISIN US72940R3003
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Yaky Yanay
Capitalización de mercado 41 Mio
País Israel
Moneda USD
Empleados 0,2 T
Dirección Matam Advanced Technology Park, Building No. 5, 3508409 Haifa
Fecha de OPV 2007-12-10

Splits de acciones

Fecha Split
25.07.2019 1:10
26.11.2007 1:200

Cambios de identificador

Fecha De A
28.12.2007 PLRS PSTI

Símbolos de cotización

Nombre Símbolo
NASDAQ PSTI

Otras acciones

Los inversores que tienen PLURISTEM THERAPEUTICSCS INC también tienen las siguientes acciones en su cartera:
AMGEN INC
AMGEN INC Acción
AUTODESK INC
AUTODESK INC Acción
BANKWELL FINANCIAL GROUP INC
BANKWELL FINANCIAL GROUP INC Acción
CISCO SYSTEMS INC
CISCO SYSTEMS INC Acción
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Acción
DEXCO INC
DEXCO INC Acción
DIREXION SHARES ETF TRUST - DIREXION DAILY FTSE CHINA BEAR 3X SHARES
DIREXION SHARES ETF TRUST - DIREXION DAILY FTSE CHINA BEAR 3X SHARES ETF
GS FDS-G.S.EUR.CO.EQ.R EO
GS FDS-G.S.EUR.CO.EQ.R EO Fondo
INTEL CORP
INTEL CORP Acción
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Acción
MICROSOFT CORP
MICROSOFT CORP Acción
NETFLIX INC
NETFLIX INC Acción
SHANG.PUDONG 24/27FLR MTN
SHANG.PUDONG 24/27FLR MTN Bono
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025